Imaging rhodopsin degeneration in vivo in a new model of ocular ischemia in living mice.


Delivery of antibodies to monitor key biomarkers of retinopathy in vivo represents a significant challenge because living cells do not take up immunoglobulins to cellular antigens. We met this challenge by developing novel contrast agents for retinopathy, which we used with magnetic resonance imaging (MRI). Biotinylated rabbit polyclonal to chick IgY… (More)
DOI: 10.1096/fj.15-280677

10 Figures and Tables


  • Presentations referencing similar topics